Randomized Placebo‐Controlled Trial Assessing the Effect of 24‐Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME‐2 Trial

BACKGROUND: There is no drug therapy for abdominal aortic aneurysm (AAA). FAME‐2 (Fenofibrate in the Management of Abdominal Aortic Aneurysm 2) was a placebo‐controlled randomized trial designed to assess whether administration of 145 mg of fenofibrate/d for 24 weeks favorably modified circulating m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Pinchbeck, Jenna L., Moxon, Joseph V., Rowbotham, Sophie E., Bourke, Michael, Lazzaroni, Sharon, Morton, Susan K., Matthews, Evan O., Hendy, Kerolos, Jones, Rhondda E., Bourke, Bernie, Jaeggi, Rene, Favot, Danella, Quigley, Frank, Jenkins, Jason S., Reid, Christopher M., Velu, Ramesh, Golledge, Jonathan
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6404864/
https://ncbi.nlm.nih.gov/pubmed/30371299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009866
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados